In humans, inhaled manganese (Mn) initiates neurodegeneration in the striatum and produces manganism, a disorder phenotypically mimetic of Parkinson's disease (PD), and it is unclear how Mn has this effect. The main route of inhaled Mn passage to striatum -via direct transneuronal transport via the olfactory system or indirectly via lungs to blood, and the relative contributions of each of these pathways -also remain unclear. The primary goal of this investigation was to explore these questions -and others -quantitatively in a rat model. An 11-compartment whole-body physiologically-based toxicokinetic (PBTK) model of Mn distribution, optimally and simultaneously fitted to a single set of multiorgan rat data was used. The fully quantified model provided numerous kinetic parameters, including the relative distribution of whole-body Mn for each compartment in response to a constant simulated input of inhaled Mn, and the relative contributions of olfactory and pulmonary pathways. The liver, which actively concentrates Mn, was found to contain the greatest percentage ($6.7%). Both the striatum and cerebellum had ($0.1%) of total Mn, which is notable given that striatum volume is approximately 100-fold less than cerebellum. The relative percentages of olfactory ($52%) and pulmonary ($48%) contributions to Mn in striatum were approximately constant computed for up to 200 days after aerosolized exposure. Following simulated acute exposure (41 mg Mn/m 3 ), clearance from striatum was nearly complete after $100 days. In a separate simulation of low-level chronic exposure ($0.01 mg Mn/m 3 ), striatal Mn was saturated and reached an approximately steady value at 100 days.